California State Teachers Retirement System (CalSTRS)’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-55,123
Closed -$304K 3394
2022
Q1
$304K Sell
55,123
-4,437
-7% -$28.2K ﹤0.01% 2560
2021
Q4
$577K Buy
59,560
+1,765
+3% +$24.5K ﹤0.01% 2457
2021
Q3
$1.03M Sell
57,795
-4,355
-7% -$94.7K ﹤0.01% 2125
2021
Q2
$1.52M Buy
62,150
+8,157
+15% +$204K ﹤0.01% 1941
2021
Q1
$1.43M Hold
53,993
﹤0.01% 1917
2020
Q4
$410K Hold
53,993
﹤0.01% 2509
2020
Q3
$271K Hold
53,993
﹤0.01% 2575
2020
Q2
$323K Hold
53,993
﹤0.01% 2464
2020
Q1
$240K Buy
53,993
+622
+1% +$4.62K ﹤0.01% 2459
2019
Q4
$507K Sell
53,371
-428
-0.8% -$4.14K ﹤0.01% 2348
2019
Q3
$422K Hold
53,799
﹤0.01% 2409
2019
Q2
$846K Buy
53,799
+992
+2% +$16K ﹤0.01% 2074
2019
Q1
$956K Buy
52,807
+33,317
+171% +$511K ﹤0.01% 1963
2018
Q4
$313K Buy
19,490
+1,100
+6% +$20.1K ﹤0.01% 2562
2018
Q3
$441K Buy
+18,390
New +$420K ﹤0.01% 2517

Other funds holding RUBY

California State Teachers Retirement System (CalSTRS)'s RUBY Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 55,123 shares — an estimated $304K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $1.52M in Q2 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 55,123 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $304K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Rubius Therapeutics, Inc position peaked at $1.52M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.